- Home
- / Personalis
Personalis
Facilities Leased (US), square feet
46 K
FY, 2021
Revenue
$85.5 M
FY, 2021
Market Capitalization
$137.9 M
2022-09-22
Personalis Summary
Company summary
- Overview
- Personalis operates as a cancer genomics company. It provides sequencing and data analysis services to support the development of cancer therapies. It also offers NeXT platform that provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.
- Type
- Public
- Founded
- 2011
- HQ
- Menlo Park, CA, US | view all locations
- Website
- https://www.personalis.com
- Cybersecurity rating
- ESG rating
- out of 100 | View all ESG data
Key people
Richard Chen, Senior Vice President Research and Development, and Chief Medical Officer
Aaron Tachibana, Senior Vice President and Chief Financial Officer
Susan Moriconi, Vice President of People and Chief Human Resources Officer
Operating MetricsView all
Patents Issued
16
23.1%
FY, 2021
Facilities Leased (US), square feet
46K
47.1%
FY, 2021
LocationsView all
3 locations detected
Menlo Park, CA HQ
United States
1330 O'Brien Dr
Shanghai, Shanghai Shi
China
1 Chengbei Rd, Jiading Qu
West Wickham
United Kingdom
Squires House, 205A High Street
Personalis Financials
Summary financials
- Revenue (Q2, 2022)
- $18.2M
- Gross profit (Q2, 2022)
- $4.3M
- Net income (Q2, 2022)
- ($27.5M)
- Cash (Q2, 2022)
- $86.7M
- EBIT (Q2, 2022)
- ($27.9M)
- Enterprise value
- $103.0M
